Loading organizations...
§ Private Profile · Gemünden, Bayern, Germany
Medical technology company developing controlled breathing drug delivery technologies, like smart nebulizers, for severe respiratory diseases.
Founded in 1998 by Gerhard Scheuch, Activaero is a Gemünden, Germany-based medical technology company developing controlled breathing drug delivery systems and smart nebulizers to treat severe respiratory diseases. The proprietary inhalation platforms of the firm, including the AKITA system, improve drug deposition efficiency in the lungs up to 85 percent compared to standard methods. Prior to its acquisition, the enterprise generated revenue through device sales, technology licensing, and research partnerships with pharmaceutical companies such as Chiesi Farmaceutici. Backed by over 14 million euros in venture capital funding from investors including LSP Life Sciences Partners and BioMedPartners, the business grew to 50 employees and generated over ten million euros in sales during 2013. In March 2014, the UK-based pharmaceutical firm Vectura Group acquired the business operation for approximately 130 million euros to expand its respiratory portfolio.
Activaero has raised $22.6M across 2 funding rounds.
Activaero has raised $22.6M in total across 2 funding rounds.
Activaero has raised $22.6M across 2 funding rounds. Most recently, it raised $6.8M Other Equity in February 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 16, 2011 | $6.8M Venture Round | Jörg Neermann | Abalis Finance, BioMedPartners, MedVenture Partners, Vesalius Biocapital, VI Partners | Announced |
| Oct 29, 2009 | $15.9M Series A | Gerhard Ries | Jean Marie Lüchinger, Christian Schneider, Arnd Kaltofen | Announced |
Activaero has raised $22.6M in total across 2 funding rounds.
Activaero's investors include Jörg Neermann, Abalis Finance, BioMedPartners, MedVenture Partners, Vesalius Biocapital, VI Partners, Gerhard Ries, Jean Marie Lüchinger, Christian Schneider, Arnd Kaltofen.